Patenting Life: Global Perspectives on Intellectual Property in Genetic and Biotechnological Innovation Amidst Ethical and Legal Challenges

The revolutionary capabilities of genetic engineering and biotechnology can revolutionize environmental conservation, agriculture and medicine. Because of this, intellectual property (IP) rights, particularly patents, are fundamental to their development, as they incentivize innovation by protecting investments in R&D. How IP works in these domains, however, raises significant questions regarding its broader implications for biodiversity, food security and public health. This research examines the correlation between intellectual property rights and innovation in biotechnology and genetic engineering, highlighting key technologies such as genetically modified organisms (GMOs), CRISPR and biopharmaceuticals. It examines the challenges of patenting these technologies, including the monopolization of genetic resources, the inability to access life-saving medicines, and the ethical dilemmas posed by the patenting of living things. Antubam, the paper highlights discrepancies on IP governance and its implications for equitable access of developing nations as opposed to developed nations. The US BRCA gene patent lawsuit and India's Section 3(d) pharmaceutical patent policy provide important insights into these difficulties. The findings of the study state that while IPR promotes innovation, it must be balanced with public interest, or it would ultimately compromise accessibility and sustainability. Because of this, it stresses the need for such IP frameworks to be transformed so that the creation of fair licensing policies to call for licensing of underpinned technology be established as well as the development of international treaties prioritizing sustainability and global health. To ensure that the genetic as well as the biotechnology engineering support the sustainable as well as the inclusive development, also maintaining its ethical standards, the study at the end makes a policy proposals which aligns with the IP law as well as the SDGs.

Authors

Institutions

Publication Details

Journal
Journal on Development of Intellectual Property and Research
Published
2025-05-08
DOI
https://doi.org/10.64618/z3gqsk52
Citations
1
Primary Topic
Intellectual Property and Patents
Type
article
Field-Weighted Citation Impact
2.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patenting Life: Global Perspectives on Intellectual Property in Genetic and Biotechnological Innovation Amidst Ethical and Legal Challenges

Rajesh Purohit, Disha Sinhmar
1 citations
Journal on Development of Intellectual Property and Research
Intellectual Property and Patents
2.76
article

Patenting Life: Global Perspectives on Intellectual Property in Genetic and Biotechnological Innovation Amidst Ethical and Legal Challenges

Rajesh Purohit, Disha Sinhmar
article en
1 citations

Abstract

The revolutionary capabilities of genetic engineering and biotechnology can revolutionize environmental conservation, agriculture and medicine. Because of this, intellectual property (IP) rights, particularly patents, are fundamental to their development, as they incentivize innovation by protecting investments in R&D. How IP works in these domains, however, raises significant questions regarding its broader implications for biodiversity, food security and public health. This research examines the correlation between intellectual property rights and innovation in biotechnology and genetic engineering, highlighting key technologies such as genetically modified organisms (GMOs), CRISPR and biopharmaceuticals. It examines the challenges of patenting these technologies, including the monopolization of genetic resources, the inability to access life-saving medicines, and the ethical dilemmas posed by the patenting of living things. Antubam, the paper highlights discrepancies on IP governance and its implications for equitable access of developing nations as opposed to developed nations. The US BRCA gene patent lawsuit and India's Section 3(d) pharmaceutical patent policy provide important insights into these difficulties. The findings of the study state that while IPR promotes innovation, it must be balanced with public interest, or it would ultimately compromise accessibility and sustainability. Because of this, it stresses the need for such IP frameworks to be transformed so that the creation of fair licensing policies to call for licensing of underpinned technology be established as well as the development of international treaties prioritizing sustainability and global health. To ensure that the genetic as well as the biotechnology engineering support the sustainable as well as the inclusive development, also maintaining its ethical standards, the study at the end makes a policy proposals which aligns with the IP law as well as the SDGs.

Journal on Development of Intellectual Property and ResearchVol. 1(1)
Savitribai Phule Pune University (IN)
Openalex Percentile: Top 9%
Intellectual Property and Patents
2.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.